Insight

Insight for 24 June 2012 - Fiji's Path to Elections

Sally Round goes to Fiji to check progress towards a new constitution and elections in 2014

Fiji Government HouseThe process of writing a new constitution is underway in Fiji. It will be the country's fourth since independence in 1970.

The regime of Commodore Frank Bainimarama abolished the 1997 constitution three years ago.

While some have decried the process as a sham and illegal, others hope that what's underway now will mean a return to democracy in elections which the interim government has promised for 2014.

Sally Round has travelled to Fiji and spoken to those spearheading the plans for a new constitution as well as regime critics, politicians and ordinary citizens.

Photo: Government Buildings in Suva.

Coming Up on Insight

8:12 am Sunday 7 February: Insight: When a Child's Home is a Car

Picture of dishes and food in a plate on the back seat

The car is home

Photo: Supplied

Lauren Baker looks into the plight of Auckland's homeless families, who, despite having jobs, still can't afford rents, and end up sleeping in cars, garages or on friends' floors.

Support workers say they're having to turn away more families than ever, while parents themselves report troubling experiences with Housing New Zealand and the Ministry of Social Development.

This Insight examines the safety-net for homeless families, and asks if the system really is helping those in desperate need of a home.

8:12 am Sunday 14 February: New Cancer Drugs and Funding Conundrums

A bright  yellow and aqua sphere, representing the immune system, sits alongside a brown cancer sphere with little goemetric shapes between indicating the drug's action

Manufacturer's illustration of how the new melanoma drug, Keytruda, stops cancer cells hiding from the immune system

Photo: Supplied

New immunotherapy drugs are the hot topic in cancer internationally. 

They stimulate the body's own immune system to fight disease, providing a possible cure for some patients. 

With the highest rates in the world of the deadly skin cancer melanoma, and no effective funded treatment for advanced disease, patients here are demanding action over the drug, Keytruda.

But the price is eye-watering and Pharmac is questioning the effectiveness.

RNZ's health correspondent, Karen Brown, investigates how good these new-generation drugs are, and the debate over whether or not NZ should fund them.